Author: Ru Liu; Xiaoyan Ming; Ou Xu; Jianli Zhou; Hui Peng; Ning Xiang; Jiaming Zhang; Hong Zhu
Title: Association of Cardiovascular Manifestations with In-hospital Outcomes in Patients with COVID-19: A Hospital Staff Data Document date: 2020_3_3
ID: 9lissxsy_37
Snippet: The analyzed population is characterized as younger age, less comorbidities than common community patients [11, 12] , and mostly featured non-severe course of There is no specific antiviral drug for SARS-CoV-2 infection up to now. Expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro, while their cytotoxicity remains in control [22] . It was reported that remdes.....
Document: The analyzed population is characterized as younger age, less comorbidities than common community patients [11, 12] , and mostly featured non-severe course of There is no specific antiviral drug for SARS-CoV-2 infection up to now. Expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro, while their cytotoxicity remains in control [22] . It was reported that remdesivir, a nucleotide analogue prodrug, in previously clinical development for treatment of Ebola virus disease, exhibited broad-spectrum . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- analogue prodrug and broad spectrum: 1, 2, 3, 4, 5, 6, 7
- analogue prodrug and cc NC ND International license: 1
- analogue prodrug and Ebola virus: 1, 2, 3, 4
- analogue prodrug and Ebola virus disease: 1
- analogue prodrug and Ebola virus disease treatment: 1
- analogue prodrug and International license: 1
- analogue prodrug and nucleotide analogue prodrug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- analogue prodrug and SARS infection: 1, 2, 3, 4, 5, 6, 7
- analyze population and chloroquine remdesivir: 1
- analyze population and SARS infection: 1, 2, 3, 4
- antiviral drug and broad spectrum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- antiviral drug and broad spectrum exhibit: 1, 2
- antiviral drug and cc NC ND International license: 1
- antiviral drug and chloroquine remdesivir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antiviral drug and community patient: 1, 2
- antiviral drug and Ebola virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
- antiviral drug and Ebola virus disease: 1, 2, 3, 4, 5
- antiviral drug and International license: 1, 2
- antiviral drug and nucleotide analogue prodrug: 1
Co phrase search for related documents, hyperlinks ordered by date